GBA1 and Parkinson disease: A knock-in GBA1 mouse model has demonstrated that increased GCA expression may also regulate SCNA expression of aS from its aggregation-prone monomeric form to a benign tetrameric form that is less prone to Lewy body aggregation, and this cellular function appears protective against motoric parkinsonism [29].